BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34260732)

  • 21. Anti-Cancer Activities of Thyrointegrin α
    Godugu K; Rajabi M; Mousa SA
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34204997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
    Ning S; Trisler K; Wessels BW; Knox SJ
    Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of tumor cell integrin αvβ3 by radiation and reversal of activation by chemically modified tetraiodothyroacetic acid (tetrac).
    Leith JT; Hercbergs A; Kenney S; Mousa SA; Davis PJ
    Endocr Res; 2018 Nov; 43(4):215-219. PubMed ID: 29611723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of novel thyrointegrin αvβ3 antagonist fb-PMT (NP751) in the management of human glioblastoma multiforme.
    Godugu K; Hay BA; Glinsky GV; Mousa SA
    Neurooncol Adv; 2023; 5(1):vdac180. PubMed ID: 36879662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.
    Yalcin M; Bharali DJ; Dyskin E; Dier E; Lansing L; Mousa SS; Davis FB; Davis PJ; Mousa SA
    Thyroid; 2010 Mar; 20(3):281-6. PubMed ID: 20187783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different
    Chin YT; He ZR; Chen CL; Chu HC; Ho Y; Su PY; Yang YSH; Wang K; Shih YJ; Chen YR; Pedersen JZ; Incerpi S; Nana AW; Tang HY; Lin HY; Mousa SA; Davis PJ; Whang-Peng J
    Front Endocrinol (Lausanne); 2019; 10():130. PubMed ID: 30915033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of fluorobenzyl polyethylene glycol conjugated tetraiodothyroacetic acid (NP751), a novel anticancer thyrointegrin α
    Fujioka K; Hay BA; Godugu K; Mousa SA
    Front Pharmacol; 2022; 13():902141. PubMed ID: 36518666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies.
    Shi S; Zhou M; Li X; Hu M; Li C; Li M; Sheng F; Li Z; Wu G; Luo M; Cui H; Li Z; Fu R; Xiang M; Xu J; Zhang Q; Lu L
    J Control Release; 2016 Aug; 235():1-13. PubMed ID: 27235150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer.
    Rajabi M; Yalcin M; Mousa SA
    Bioorg Med Chem Lett; 2018 Apr; 28(7):1223-1227. PubMed ID: 29519736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro effects of tetraiodothyroacetic acid combined with X-irradiation on basal cell carcinoma cells.
    Leith JT; Davis PJ; Mousa SA; Hercbergs AA
    Cell Cycle; 2017 Feb; 16(4):367-373. PubMed ID: 28113001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor.
    Lee S; Kim J; Shim G; Kim S; Han SE; Kim K; Kwon IC; Choi Y; Kim YB; Kim CW; Oh YK
    J Control Release; 2012 Dec; 164(2):213-20. PubMed ID: 22664473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.
    Schütze C; Dörfler A; Eicheler W; Zips D; Hering S; Solca F; Baumann M; Krause M
    Strahlenther Onkol; 2007 May; 183(5):256-64. PubMed ID: 17497097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting Thyrointegrin αvβ3 Using Fluorobenzyl Polyethylene Glycol Conjugated Tetraiodothyroacetic Acid (NP751) in Acute Myeloid Leukemia.
    Darwish NHE; Glinsky GV; Sudha T; Mousa SA
    Front Oncol; 2021; 11():793810. PubMed ID: 35155195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiosensitization and production of DNA double-strand breaks in U87MG brain tumor cells induced by tetraiodothyroacetic acid (tetrac).
    Hercbergs AH; Lin HY; Davis FB; Davis PJ; Leith JT
    Cell Cycle; 2011 Jan; 10(2):352-7. PubMed ID: 21212737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiosensitization of non-small-cell lung cancer cells and xenografts by the interactive effects of pemetrexed and methoxyamine.
    Oleinick NL; Biswas T; Patel R; Tao M; Patel R; Weeks L; Sharma N; Dowlati A; Gerson SL; Fu P; Zhang J; Machtay M
    Radiother Oncol; 2016 Nov; 121(2):335-341. PubMed ID: 27838149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AZD5438, an inhibitor of Cdk1, 2, and 9, enhances the radiosensitivity of non-small cell lung carcinoma cells.
    Raghavan P; Tumati V; Yu L; Chan N; Tomimatsu N; Burma S; Bristow RG; Saha D
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e507-14. PubMed ID: 22795803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system.
    Lin HY; Landersdorfer CB; London D; Meng R; Lim CU; Lin C; Lin S; Tang HY; Brown D; Van Scoy B; Kulawy R; Queimado L; Drusano GL; Louie A; Davis FB; Mousa SA; Davis PJ
    PLoS Comput Biol; 2011 Feb; 7(2):e1001073. PubMed ID: 21304935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy.
    Burdelya LG; Gleiberman AS; Toshkov I; Aygun-Sunar S; Bapardekar M; Manderscheid-Kern P; Bellnier D; Krivokrysenko VI; Feinstein E; Gudkov AV
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):228-34. PubMed ID: 22000579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.
    Shen LF; Zhao X; Zhou SH; Lu ZJ; Zhao K; Fan J; Zhou ML
    Oncotarget; 2017 May; 8(21):34709-34726. PubMed ID: 28410229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetrac-conjugated polymersomes for integrin-targeted delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
    Alibolandi M; Rezvani R; Farzad SA; Taghdisi SM; Abnous K; Ramezani M
    Int J Pharm; 2017 Oct; 532(1):581-594. PubMed ID: 28935257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.